| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8681633 | Clinical Neurology and Neurosurgery | 2018 | 17 Pages |
Abstract
In patients with postsurgical myelopathy, surgeons should evaluate B12 status and consider the possibility that nitrous oxide could cause a subclinical B12 deficiency to become overt, particularly in patients with malabsorptive GI comorbidities. Treatment with B12 in this population can result in significant improvement of neurological function.
Keywords
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Kishan K. Patel, Juan Carlos Mejia Munne, Vimal Raj Nitish Gunness, Denise Hersey, Nabeel Alshafai, Daniel Sciubba, Rani Nasser, David Gimbel, Joseph Cheng, Aria Nouri,